Secondary Data Analysis for Neonates with Retinal OCT Imaging
Secondary Data Analysis for Neonates with Retinal OCT Imaging
批准号:
10707461
负责人:
CYNTHIA ANN TOTH
金额:
$20.19万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-30 至 2024-08-31
关键词:
AdultAgeAnatomyBiologicalBirthBlindnessBlood VesselsCaringCharacteristicsClassificationClinicalClinical DataClinical ResearchClinical TrialsClinical and Translational Science AwardsColorComparison armCystoid Macular EdemaDataData AnalysesData SetDiagnosisDiseaseDisease MarkerEarly identificationEnrollmentEvaluationEyeFoundationsFundingFundusFutureGanglion Cell LayerGleanGoalsHealthImageImaging DeviceInfantLightLightingLocationLongitudinal StudiesMeasurableMeasuresMethodologyMethodsMicroanatomyMorphologyNational Center for Research ResourcesNoseObservational StudyOptic NerveOptical Coherence TomographyOptical MethodsOpticsOutcomeParticipantPatternPeripheralPhotographyPigmentation physiologic functionPremature InfantProtocols documentationRaceReproducibilityResearchRetinaRetinal NeovascularizationRetinopathy of PrematurityRiskRisk MarkerSeveritiesSeverity of illnessStressSystemTelemedicineTestingTherapeutic InterventionTherapy trialThickTimeUnited States National Institutes of HealthVascular DiseasesVisitWorkclinical predictorsdiagnostic toolextreme prematurityfundus imaginghealth dataimaging modalityimprovedinfant monitoringinflammatory markerinsightmaculaneonatal hypoxic-ischemic brain injuryneonatepreventprospectiveretinal imagingretinal nerve fiber layerscreeningsecondary analysissuccessusability
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The Secondary Data Analysis for Neonates with Retinal OCT Imaging includes data from 330 infant participants
previously enrolled into prospective observational studies which included use of investigational OCT devices for
imaging at the bedside. These data have been divided into two groups: the Retinopathy of Prematurity (ROP)
Group and the Healthy Term Infant Group. The ROP Group consists of data from 239 preterm infants evaluated
for ROP from the following studies: The Hartwell Foundation funded Spectral Domain Optical Coherence
Tomography Imaging of Infant Eyes: A Practical Diagnostic Tool and Methodology, the Research to Prevent
Blindness funded Association of Inflammatory Markers and Cystoid Macular Edema in Very Preterm Infants, a
pilot National Center for Research Resources - Clinical and Translational Science Award, Bedside Optical
Assessment of Hypoxic Ischemic Encephalopathy in Infants, and the NIH funded Analyzing Retinal
Microanatomy in Retinopathy of Prematurity to Improve Care (called BabySTEPS) study. The Healthy Term
Infant Group consists of data from 91 infants enrolled as healthy term infants in a comparison arm in the first two
studies above or in the NIH funded Bedside Optical Retinal Assessment of Hypoxic Ischemic Encephalopathy
in Infants study. The specific aims of this proposal do not overlap with the aims of any of the aforementioned
studies. The proposed secondary analyses study of these unique data will be performed to achieve the following:
(1) Determine if ganglion cell layer thickness in the nasal macula is highly correlated with and less variable from
visit to visit than retinal nerve fiber layer thickness in the papillomacular bundle; (2) Develop more objective,
efficient, and rigorous analysis of OCT data related to vascular disease severity by incorporating cross-sectional
(thickness) and en face OCT measures to score vascular disease in ROP: (a) at time of clinical pre-plus and
plus disease, and (b) preceding onset of greater vascular disease severity; (3) Evaluate the utility of very early
retinal and choroidal OCT measures to provide early prediction of clinical ROP severity; (4) Evaluate fundus
pigmentation as a biological variable more closely correlated to foveal pit morphology in preterm infants in
contrast to racial classification; and (5) Define the difference in measures and features on OCT at term equivalent
age between preterm with minimal ROP, preterm with ROP and term infants, considering biological variables. A
goal of this proposal is to perform the secondary analysis on unique existing OCT data to optimize the analysis
of preterm infant OCT data for more efficient use for clinical trials and future telemedicine uses in ROP. Additional
goals are to identify early markers of risk of advanced ROP or progression, to refine methods for image grading
to optimize accuracy and efficiency, and to establish the differences between these OCT measures and those
in term-born infants. This work has great potential to be of benefit for clinical research and eye care of premature
infants worldwide.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Secondary Data Analysis for Neonates with Retinal OCT Imaging
-
批准号:10508609
-
项目类别:
-
资助金额:$25.74万
-
财政年份:2022
-
负责人:CYNTHIA ANN TOTH
-
依托单位:
Bedside Optical Retinal Assessment of Hypoxic Ischemic Encephalopathy in Infants
-
批准号:9752557
-
项目类别:
-
资助金额:$20.04万
-
财政年份:2018
-
负责人:CYNTHIA ANN TOTH
-
依托单位:
Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care
-
批准号:10398145
-
项目类别:
-
资助金额:$58.86万
-
财政年份:2016
-
负责人:CYNTHIA ANN TOTH
-
依托单位:
Analyzing retinal microanatomy in retinopathy of prematurity to improve care
-
批准号:9029536
-
项目类别:
-
资助金额:$69.75万
-
财政年份:2016
-
负责人:CYNTHIA ANN TOTH
-
依托单位:
Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care
-
批准号:10210847
-
项目类别:
-
资助金额:$62.22万
-
财政年份:2016
-
负责人:CYNTHIA ANN TOTH
-
依托单位:
Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care
-
批准号:10596546
-
项目类别:
-
资助金额:$59.89万
-
财政年份:2016
-
负责人:CYNTHIA ANN TOTH
-
依托单位:
Analyzing retinal microanatomy in retinopathy of prematurity to improve care
-
批准号:9238769
-
项目类别:
-
资助金额:$71.34万
-
财政年份:2016
-
负责人:CYNTHIA ANN TOTH
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: